#

19-21 SEPTEMBER 2017 //

 BERLIN, GERMANY

Speakers

Loading
Bernd Leistler

Dr Bernd Leistler

Vice President Development & Production, CellGenix

Bernd Leistler joined CellGenix in 2003. Among others he acted as Qualified Person for therapeutic recombinant vaccines. Today, as Director of Development & Production, he is responsible for all products, including media and cytokines for ex vivo cell processing. Bernd has a long track record as a protein specialist. Following his degree in chemistry he joined the Basel Biocenter for his dissertation on studies of structure, function, folding and assembly of oligomeric proteins. He continued these studies as a postgraduate researcher in Cambridge, UK. His professional carreer started in 1993 at a leading manufacturer of diagnostic autoantibody immunoassays which later became part of Pharmacia Diagnostics. For Pharmacia Diagnostics Dr. Leistler managed the Biotechnology Department and developed it as a corporate service unit for recombinant and conventional human autoantigens and allergens.

Sessions

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad

Sponsors

  • #
  • #
  • #
  • #
  • TrakCel, Silver Sponsor at Cell & Gene Therapy Europe
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #
  • #